James R. Cerhan
Statistics and Probability · 2004–2018
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 7 citations into it
Whom James R. Cerhan trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Bradley Efron (in Statistics and Probability)
Who trusts James R. Cerhan
- M. F. Holick (in Pathology and Forensic Medicine)
Papers from James R. Cerhan's perspective
Ordered by how strongly the researchers James R. Cerhan trusts endorse each paper. Same corpus, a different order for every researcher.
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (Nature)
- Bootstrap Methods: Another Look at the Jackknife
- SEER Cancer Statistics Review, 1975-2003
- Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. (Journal of the American Medical Association (JAMA))
- Pathology and genetics: Tumours of haematopoietic and lymphoid tissues
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. (Blood)
- Patterns of somatic mutation in human cancer genomes (Nature)
- Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas (Nature)
- Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. (Blood)
- Initial genome sequencing and analysis of multiple myeloma (Nature)
Their papers
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing (2012) — 1,002 citations
- Molecular Subtypes of Diffuse Large B-cell Lymphoma are Associated with Distinct Pathogenic Mechanisms and Outcomes (2018) — 1,686 citations
- Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. (2017) — 1,571 citations
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes (2016) — 1,061 citations
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents (2016) — 2,332 citations
- Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study. (2015) — 747 citations
- Type I and II endometrial cancers: have they different risk factors? (2013) — 749 citations
- Body-Mass Index and Mortality among 1.46 Million White Adults (2010) — 1,167 citations
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. (2008) — 608 citations
- Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. (2004) — 823 citations
- Epidemiologic Evaluation of Measurement Data in the Presence of Detection Limits (2004) — 628 citations